Activist 13D/13G Filings - CITADEL ADVISORS LLC

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, ...35, 36, Next
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2024-04-25
5:51 pm
Purchase
13GMARINUS PHARMACEUTICALS INC
MRNS
CITADEL ADVISORS LLC222,335
0.4%
222,335increase
(New Position)
View
2024-04-22
4:05 pm
Purchase
13GProtara Therapeutics Inc.
TARA
CITADEL ADVISORS LLC1,213,132
5.7%
1,213,132increase
(New Position)
View
2024-03-25
4:12 pm
Purchase
13GREV Group Inc.
REVG
CITADEL ADVISORS LLC2,697,273
5.2%
2,697,273increase
(New Position)
View
2024-03-22
4:43 pm
Purchase
13GCUMMINS INC
CMI
CITADEL ADVISORS LLC263,557
0.2%
263,557increase
(New Position)
View
2024-03-18
4:13 pm
Purchase
13GATARA BIOTHERAPEUTICS INC
ATRA
CITADEL ADVISORS LLC6,533,119
6.4%
6,533,119increase
(New Position)
View
2024-02-23
4:01 pm
Purchase
13GHELIX ACQUISITION CORP II
HLXB
CITADEL ADVISORS LLC1,322,155
7%
1,322,155increase
(New Position)
View
2024-02-14
6:18 pm
Purchase
13GLYRA THERAPEUTICS INC
LYRA
CITADEL ADVISORS LLC4,286,927
7.9%
1,390,392increase
(+48.00%)
View
2024-02-14
6:18 pm
Sale
13GJASPER THERAPEUTICS INC WTS EX
JSPRW
CITADEL ADVISORS LLC230,620
0.2%
-3,498,450decrease
(-93.82%)
View
2024-02-14
6:18 pm
Sale
13GHarpoon Therapeutics Inc.
HARP
CITADEL ADVISORS LLC1,027,956
6%
-3decrease
(-0.00%)
View
2024-02-14
6:18 pm
Sale
13GBlink Charging Co.
BLNK
CITADEL ADVISORS LLC426,857
0.6%
-1,967,591decrease
(-82.17%)
View
2024-02-14
6:18 pm
Purchase
13GVISTAGEN THERAPEUTICS INC
VTGN
CITADEL ADVISORS LLC1,600,768
5.8%
6,832increase
(+0.43%)
View
2024-02-14
6:18 pm
Sale
13GGroupon Inc.
GRPN
CITADEL ADVISORS LLC1,273,880
4%
-70,624decrease
(-5.25%)
View
2024-02-14
6:18 pm
Purchase
13GALLURION TECHNOLOGIES INC.
ALUR
CITADEL ADVISORS LLC2,563,726
5.1%
6,609increase
(+0.26%)
View
2024-02-14
6:18 pm
Purchase
13GIntuitive Machines Inc.
EDR
CITADEL ADVISORS LLC843,505
3.9%
843,505increase
(New Position)
View
2024-02-14
6:18 pm
Sale
13GAppreciate Holdings Inc.
SFRT
CITADEL ADVISORS LLC965,611
5.4%
-154,481decrease
(-13.79%)
View
2024-02-14
6:18 pm
Purchase
13GACELYRIN Inc.
SLRN
CITADEL ADVISORS LLC6,649,442
6.8%
685,642increase
(+11.50%)
View
2024-02-14
6:18 pm
Sale
13GBenitec Biopharma Inc.
BNTC
CITADEL ADVISORS LLC95,356
3.6%
-84,674decrease
(-47.03%)
View
2024-02-14
6:18 pm
Sale
13GClene Inc.
CLNN
CITADEL ADVISORS LLC6,050,326
4.5%
-1,574,065decrease
(-20.65%)
View
2024-02-14
6:18 pm
Sale
13GAPPLIED OPTOELECTRONICS INC.
AAOI
CITADEL ADVISORS LLC506,340
1.2%
-1,324,593decrease
(-72.35%)
View
2024-02-14
4:58 pm
Sale
13GAerovate Therapeutics Inc.
AVTE
CITADEL ADVISORS LLC3,276
0%
-1,558,705decrease
(-99.79%)
View
Goto 0, 1, 2, ...35, 36, Next